Last 12 months
Inside the activity.
0 purchase rows · 106 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 10 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 7 |
| Mar 2026 | 0 | 10 |
| Apr 2026 | 0 | 6 |
| May 2026 | 0 | 13 |
| Jun 2026 | 0 | 11 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 12 |
| Sep 2026 | 0 | 11 |
| Oct 2026 | 0 | 16 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 16, 2026 Filed Feb 17, 2026 23:51 UTC |
Torley HelenDirector · PRESIDENT AND CEO
|
Tax withholdingCommon Stock | 27,605 | $79.44 | $2,192,941.20 |
DisclosureSEC source: 0001159036-26-000025 · wk-form4_1771372286.xml · nonDerivative · entry 6 Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 749,731 F3 · shares: The reported disposition of 27,605 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations. Read SEC document |
| February 16, 2026 Filed Feb 17, 2026 23:51 UTC |
Torley HelenDirector · PRESIDENT AND CEO
|
Exercise / conversionCommon Stock | 51,171 | $0.00 | $0.00 |
DisclosureSEC source: 0001159036-26-000025 · wk-form4_1771372286.xml · nonDerivative · entry 5 Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 777,336 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2026 Filed Feb 17, 2026 23:51 UTC |
Torley HelenDirector · PRESIDENT AND CEO
|
Tax withholdingCommon Stock | 9,104 | $79.44 | $723,221.76 |
DisclosureSEC source: 0001159036-26-000025 · wk-form4_1771372286.xml · nonDerivative · entry 4 Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 726,165 F2 · shares: The reported disposition of 9,104 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations. Read SEC document |
| February 16, 2026 Filed Feb 17, 2026 23:51 UTC |
Torley HelenDirector · PRESIDENT AND CEO
|
Exercise / conversionCommon Stock | 16,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001159036-26-000025 · wk-form4_1771372286.xml · nonDerivative · entry 3 Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 735,269 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2026 Filed Feb 17, 2026 23:51 UTC |
Torley HelenDirector · PRESIDENT AND CEO
|
Tax withholdingCommon Stock | 11,334 | $79.44 | $900,372.96 |
DisclosureSEC source: 0001159036-26-000025 · wk-form4_1771372286.xml · nonDerivative · entry 2 Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 718,394 F1 · shares: The reported disposition of 11,334 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations. Read SEC document |
| February 16, 2026 Filed Feb 17, 2026 23:51 UTC |
Torley HelenDirector · PRESIDENT AND CEO
|
Exercise / conversionCommon Stock | 21,009 | $0.00 | $0.00 |
DisclosureSEC source: 0001159036-26-000025 · wk-form4_1771372286.xml · nonDerivative · entry 1 Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 729,728 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2026 Filed Feb 12, 2026 02:21 UTC |
Caudill CortneySVP, CHIEF OPERATING OFFICER
|
GrantPerformance Stock Units · Derivative | 14,751 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001159036-26-000017 · wk-form4_1770862890.xml · derivative · entry 4 Caudill Cortney · CIK 0002090209 · SVP, CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,751 Underlying: Common Stock · 14,751 shares Expires not disclosed F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 20, 2025 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date. F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 20, 2025 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date. Read SEC document |
| February 09, 2026 Filed Feb 12, 2026 02:21 UTC |
Caudill CortneySVP, CHIEF OPERATING OFFICER
|
GrantPerformance Stock Units · Derivative | 2,403 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001159036-26-000017 · wk-form4_1770862890.xml · derivative · entry 3 Caudill Cortney · CIK 0002090209 · SVP, CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,886 Underlying: Common Stock · 2,403 shares Expires not disclosed F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 23, 2024 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 23, 2024 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date. Read SEC document |
| February 09, 2026 Filed Feb 12, 2026 02:21 UTC |
Caudill CortneySVP, CHIEF OPERATING OFFICER
|
GrantRestricted Stock Units · Derivative | 13,047 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001159036-26-000017 · wk-form4_1770862890.xml · derivative · entry 2 Caudill Cortney · CIK 0002090209 · SVP, CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,047 Underlying: Common Stock · 13,047 shares Expires not disclosed F2 · derivative.exercise_date: This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter. F2 · derivative.expiration_date: This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter. Read SEC document |
| February 09, 2026 Filed Feb 12, 2026 02:21 UTC |
Caudill CortneySVP, CHIEF OPERATING OFFICER
|
GrantOption to Purchase Common Stock · Derivative | 14,047 | $0.00 Strike: $80.48 | $0.00 |
DisclosureSEC source: 0001159036-26-000017 · wk-form4_1770862890.xml · derivative · entry 1 Caudill Cortney · CIK 0002090209 · SVP, CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,047 Underlying: Common Stock · 14,047 shares Expires 2036-02-09 F1 · derivative.exercise_date: This option vests one-fourth on such date and then 1/48th monthly thereafter. Read SEC document |
| February 09, 2026 Filed Feb 12, 2026 02:20 UTC |
Snyder Mark HowardSVP, CHIEF LEGAL OFFICER
|
GrantPerformance Stock Units · Derivative | 29,502 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001159036-26-000016 · wk-form4_1770862856.xml · derivative · entry 5 Snyder Mark Howard · CIK 0001902866 · SVP, CHIEF LEGAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,502 Underlying: Common Stock · 29,502 shares Expires not disclosed F5 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 20, 2025 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date. F5 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 20, 2025 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date. Read SEC document |
| February 09, 2026 Filed Feb 12, 2026 02:20 UTC |
Snyder Mark HowardSVP, CHIEF LEGAL OFFICER
|
GrantPerformance Stock Units · Derivative | 7,808 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001159036-26-000016 · wk-form4_1770862856.xml · derivative · entry 4 Snyder Mark Howard · CIK 0001902866 · SVP, CHIEF LEGAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,127 Underlying: Common Stock · 7,808 shares Expires not disclosed F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 23, 2024 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date. F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 23, 2024 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date. Read SEC document |
| February 09, 2026 Filed Feb 12, 2026 02:20 UTC |
Snyder Mark HowardSVP, CHIEF LEGAL OFFICER
|
GrantPerformance Stock Units · Derivative | 4,651 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001159036-26-000016 · wk-form4_1770862856.xml · derivative · entry 3 Snyder Mark Howard · CIK 0001902866 · SVP, CHIEF LEGAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,016 Underlying: Common Stock · 4,651 shares Expires not disclosed F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 16, 2023 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 16, 2023 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date. Read SEC document |
| February 09, 2026 Filed Feb 12, 2026 02:20 UTC |
Snyder Mark HowardSVP, CHIEF LEGAL OFFICER
|
GrantRestricted Stock Units · Derivative | 17,396 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001159036-26-000016 · wk-form4_1770862856.xml · derivative · entry 2 Snyder Mark Howard · CIK 0001902866 · SVP, CHIEF LEGAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,396 Underlying: Common Stock · 17,396 shares Expires not disclosed F2 · derivative.exercise_date: This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter. F2 · derivative.expiration_date: This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter. Read SEC document |
| February 09, 2026 Filed Feb 12, 2026 02:20 UTC |
Snyder Mark HowardSVP, CHIEF LEGAL OFFICER
|
GrantOption to Purchase Common Stock · Derivative | 18,730 | $0.00 Strike: $80.48 | $0.00 |
DisclosureSEC source: 0001159036-26-000016 · wk-form4_1770862856.xml · derivative · entry 1 Snyder Mark Howard · CIK 0001902866 · SVP, CHIEF LEGAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,730 Underlying: Common Stock · 18,730 shares Expires 2036-02-09 F1 · derivative.exercise_date: This option vests one-fourth on such date and then 1/48th monthly thereafter. Read SEC document |
| February 09, 2026 Filed Feb 12, 2026 02:20 UTC |
LaBrosse NicoleSVP, CHIEF FINANCIAL OFFICER
|
GrantPerformance Stock Units · Derivative | 29,502 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001159036-26-000015 · wk-form4_1770862831.xml · derivative · entry 3 LaBrosse Nicole · CIK 0001910662 · SVP, CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,502 Underlying: Common Stock · 29,502 shares Expires not disclosed F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 20, 2025 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 20, 2025 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date. Read SEC document |
| February 09, 2026 Filed Feb 12, 2026 02:20 UTC |
LaBrosse NicoleSVP, CHIEF FINANCIAL OFFICER
|
GrantPerformance Stock Units · Derivative | 7,448 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001159036-26-000015 · wk-form4_1770862831.xml · derivative · entry 2 LaBrosse Nicole · CIK 0001910662 · SVP, CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,045 Underlying: Common Stock · 7,448 shares Expires not disclosed F2 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 23, 2024 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 23, 2024 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date. Read SEC document |
| February 09, 2026 Filed Feb 12, 2026 02:20 UTC |
LaBrosse NicoleSVP, CHIEF FINANCIAL OFFICER
|
GrantPerformance Stock Units · Derivative | 5,167 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001159036-26-000015 · wk-form4_1770862831.xml · derivative · entry 1 LaBrosse Nicole · CIK 0001910662 · SVP, CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,351 Underlying: Common Stock · 5,167 shares Expires not disclosed F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 16, 2023 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 16, 2023 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date. Read SEC document |
| February 09, 2026 Filed Feb 12, 2026 01:56 UTC |
Torley HelenDirector · PRESIDENT AND CEO
|
GrantPerformance Stock Units · Derivative | 92,714 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001159036-26-000014 · wk-form4_1770861390.xml · derivative · entry 5 Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,714 Underlying: Common Stock · 92,714 shares Expires not disclosed F5 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 20, 2025 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date. F5 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 20, 2025 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date. Read SEC document |
| February 09, 2026 Filed Feb 12, 2026 01:56 UTC |
Torley HelenDirector · PRESIDENT AND CEO
|
GrantPerformance Stock Units · Derivative | 24,985 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001159036-26-000014 · wk-form4_1770861390.xml · derivative · entry 4 Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,400 Underlying: Common Stock · 24,985 shares Expires not disclosed F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 23, 2024 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date. F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 23, 2024 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date. Read SEC document |
| February 09, 2026 Filed Feb 12, 2026 01:56 UTC |
Torley HelenDirector · PRESIDENT AND CEO
|
GrantPerformance Stock Units · Derivative | 19,807 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001159036-26-000014 · wk-form4_1770861390.xml · derivative · entry 3 Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,171 Underlying: Common Stock · 19,807 shares Expires not disclosed F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 16, 2023 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 16, 2023 that included a performance measurement period ending December 31, 2025. This transaction represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date. Read SEC document |
| February 09, 2026 Filed Feb 12, 2026 01:56 UTC |
Torley HelenDirector · PRESIDENT AND CEO
|
GrantRestricted Stock Units · Derivative | 50,013 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001159036-26-000014 · wk-form4_1770861390.xml · derivative · entry 2 Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,013 Underlying: Common Stock · 50,013 shares Expires not disclosed F2 · derivative.exercise_date: This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter. F2 · derivative.expiration_date: This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter. Read SEC document |
| February 09, 2026 Filed Feb 12, 2026 01:56 UTC |
Torley HelenDirector · PRESIDENT AND CEO
|
GrantOption to Purchase Common Stock · Derivative | 53,847 | $0.00 Strike: $80.48 | $0.00 |
DisclosureSEC source: 0001159036-26-000014 · wk-form4_1770861390.xml · derivative · entry 1 Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,847 Underlying: Common Stock · 53,847 shares Expires 2036-02-09 F1 · derivative.exercise_date: This option vests one-fourth on such date and then 1/48th monthly thereafter. Read SEC document |
| February 05, 2026 Filed Feb 6, 2026 00:38 UTC |
Torley HelenDirector · PRESIDENT AND CEO
|
Exercise / conversionOption to Purchase Common Stock · Derivative | 10,000 | $12.07 Strike: $12.07 | $120,700.00 |
DisclosureSEC source: 0001159036-26-000012 · wk-form4_1770338320.xml · derivative · entry 13 Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 201,923 Underlying: Common Stock · 10,000 shares Expires 2027-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 21, 2025 in accordance with Rule 10b5-1. The sales of common shares reported on this Form 4 represent shares that were acquired following exercise of stock options with a ten-year term expiring in February 2027. F9 · derivative.exercise_date: Grant to Reporting Person of options, exercisable over a 4-year period measured from the date of grant, 25% after 12 months, then 1/48th of the Option Shares per month thereafter. The date of grant was February 22, 2017. Read SEC document |
| February 05, 2026 Filed Feb 6, 2026 00:38 UTC |
Torley HelenDirector · PRESIDENT AND CEO
|
SaleCommon Stock | 4,624 | $78.94 | $365,000.06 |
DisclosureSEC source: 0001159036-26-000012 · wk-form4_1770338320.xml · nonDerivative · entry 10 Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 708,719 F1 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 21, 2025 in accordance with Rule 10b5-1. The sales of common shares reported on this Form 4 represent shares that were acquired following exercise of stock options with a ten-year term expiring in February 2027. F8 · price: Represents a weighted average sales price per share. The shares were sold at prices ranging from $78.643 to $79.292. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 05, 2026 Filed Feb 6, 2026 00:38 UTC |
Torley HelenDirector · PRESIDENT AND CEO
|
SaleCommon Stock | 5,376 | $78.38 | $421,365.50 |
DisclosureSEC source: 0001159036-26-000012 · wk-form4_1770338320.xml · nonDerivative · entry 9 Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 713,343 F1 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 21, 2025 in accordance with Rule 10b5-1. The sales of common shares reported on this Form 4 represent shares that were acquired following exercise of stock options with a ten-year term expiring in February 2027. F7 · price: Represents a weighted average sales price per share. The shares were sold at prices ranging from $77.640 to $78.637. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 05, 2026 Filed Feb 6, 2026 00:38 UTC |
Torley HelenDirector · PRESIDENT AND CEO
|
Exercise / conversionCommon Stock | 10,000 | $12.07 | $120,700.00 |
DisclosureSEC source: 0001159036-26-000012 · wk-form4_1770338320.xml · nonDerivative · entry 8 Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 718,719 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 21, 2025 in accordance with Rule 10b5-1. The sales of common shares reported on this Form 4 represent shares that were acquired following exercise of stock options with a ten-year term expiring in February 2027. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 00:38 UTC |
Torley HelenDirector · PRESIDENT AND CEO
|
Exercise / conversionOption to Purchase Common Stock · Derivative | 20,000 | $12.07 Strike: $12.07 | $241,400.00 |
DisclosureSEC source: 0001159036-26-000012 · wk-form4_1770338320.xml · derivative · entry 12 Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 211,923 Underlying: Common Stock · 20,000 shares Expires 2027-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 21, 2025 in accordance with Rule 10b5-1. The sales of common shares reported on this Form 4 represent shares that were acquired following exercise of stock options with a ten-year term expiring in February 2027. F9 · derivative.exercise_date: Grant to Reporting Person of options, exercisable over a 4-year period measured from the date of grant, 25% after 12 months, then 1/48th of the Option Shares per month thereafter. The date of grant was February 22, 2017. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 00:38 UTC |
Torley HelenDirector · PRESIDENT AND CEO
|
SaleCommon Stock | 10,100 | $77.54 | $783,154.00 |
DisclosureSEC source: 0001159036-26-000012 · wk-form4_1770338320.xml · nonDerivative · entry 7 Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 708,719 F1 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 21, 2025 in accordance with Rule 10b5-1. The sales of common shares reported on this Form 4 represent shares that were acquired following exercise of stock options with a ten-year term expiring in February 2027. F6 · price: Represents a weighted average sales price per share. The shares were sold at prices ranging from $77.290 to $77.990. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 00:38 UTC |
Torley HelenDirector · PRESIDENT AND CEO
|
SaleCommon Stock | 9,900 | $76.94 | $761,666.40 |
DisclosureSEC source: 0001159036-26-000012 · wk-form4_1770338320.xml · nonDerivative · entry 6 Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 718,819 F1 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 21, 2025 in accordance with Rule 10b5-1. The sales of common shares reported on this Form 4 represent shares that were acquired following exercise of stock options with a ten-year term expiring in February 2027. F5 · price: Represents a weighted average sales price per share. The shares were sold at prices ranging from $76.275 to $77.260. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 00:38 UTC |
Torley HelenDirector · PRESIDENT AND CEO
|
Exercise / conversionCommon Stock | 20,000 | $12.07 | $241,400.00 |
DisclosureSEC source: 0001159036-26-000012 · wk-form4_1770338320.xml · nonDerivative · entry 5 Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 728,719 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 21, 2025 in accordance with Rule 10b5-1. The sales of common shares reported on this Form 4 represent shares that were acquired following exercise of stock options with a ten-year term expiring in February 2027. Read SEC document |
| February 03, 2026 Filed Feb 6, 2026 00:38 UTC |
Torley HelenDirector · PRESIDENT AND CEO
|
Exercise / conversionOption to Purchase Common Stock · Derivative | 20,000 | $12.07 Strike: $12.07 | $241,400.00 |
DisclosureSEC source: 0001159036-26-000012 · wk-form4_1770338320.xml · derivative · entry 11 Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 231,923 Underlying: Common Stock · 20,000 shares Expires 2027-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 21, 2025 in accordance with Rule 10b5-1. The sales of common shares reported on this Form 4 represent shares that were acquired following exercise of stock options with a ten-year term expiring in February 2027. F9 · derivative.exercise_date: Grant to Reporting Person of options, exercisable over a 4-year period measured from the date of grant, 25% after 12 months, then 1/48th of the Option Shares per month thereafter. The date of grant was February 22, 2017. Read SEC document |
| February 03, 2026 Filed Feb 6, 2026 00:38 UTC |
Torley HelenDirector · PRESIDENT AND CEO
|
SaleCommon Stock | 7,790 | $76.73 | $597,757.86 |
DisclosureSEC source: 0001159036-26-000012 · wk-form4_1770338320.xml · nonDerivative · entry 4 Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 708,719 F1 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 21, 2025 in accordance with Rule 10b5-1. The sales of common shares reported on this Form 4 represent shares that were acquired following exercise of stock options with a ten-year term expiring in February 2027. F4 · price: Represents a weighted average sales price per share. The shares were sold at prices ranging from $76.490 to $77.030. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 03, 2026 Filed Feb 6, 2026 00:38 UTC |
Torley HelenDirector · PRESIDENT AND CEO
|
SaleCommon Stock | 9,659 | $75.94 | $733,543.10 |
DisclosureSEC source: 0001159036-26-000012 · wk-form4_1770338320.xml · nonDerivative · entry 3 Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 716,509 F1 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 21, 2025 in accordance with Rule 10b5-1. The sales of common shares reported on this Form 4 represent shares that were acquired following exercise of stock options with a ten-year term expiring in February 2027. F3 · price: Represents a weighted average sales price per share. The shares were sold at prices ranging from $75.470 to $76.460. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 03, 2026 Filed Feb 6, 2026 00:38 UTC |
Torley HelenDirector · PRESIDENT AND CEO
|
SaleCommon Stock | 2,551 | $74.88 | $191,016.33 |
DisclosureSEC source: 0001159036-26-000012 · wk-form4_1770338320.xml · nonDerivative · entry 2 Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 726,168 F1 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 21, 2025 in accordance with Rule 10b5-1. The sales of common shares reported on this Form 4 represent shares that were acquired following exercise of stock options with a ten-year term expiring in February 2027. F2 · price: Represents a weighted average sales price per share. The shares were sold at prices ranging from $74.450 to $75.442. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| February 03, 2026 Filed Feb 6, 2026 00:38 UTC |
Torley HelenDirector · PRESIDENT AND CEO
|
Exercise / conversionCommon Stock | 20,000 | $12.07 | $241,400.00 |
DisclosureSEC source: 0001159036-26-000012 · wk-form4_1770338320.xml · nonDerivative · entry 1 Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 728,719 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 21, 2025 in accordance with Rule 10b5-1. The sales of common shares reported on this Form 4 represent shares that were acquired following exercise of stock options with a ten-year term expiring in February 2027. Read SEC document |
| January 05, 2026 Filed Jan 6, 2026 23:55 UTC |
Connaughton BernadetteDirector
|
SaleCommon Stock | 2,000 | $70.25 | $140,500.00 |
DisclosureSEC source: 0001159036-26-000006 · wk-form4_1767743752.xml · nonDerivative · entry 1 Connaughton Bernadette · CIK 0001662521 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,123 F1 · kind: The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on May 29, 2025 in accordance with Rule 10b5-1. Read SEC document |
| January 03, 2026 Filed Jan 6, 2026 23:55 UTC |
Snyder Mark HowardSVP, CHIEF LEGAL OFFICER
|
Exercise / conversionRestricted Stock Units · Derivative | 7,611 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001159036-26-000005 · wk-form4_1767743723.xml · derivative · entry 3 Snyder Mark Howard · CIK 0001902866 · SVP, CHIEF LEGAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,611 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. F2 · derivative.expiration_date: This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. Read SEC document |
| January 03, 2026 Filed Jan 6, 2026 23:55 UTC |
Snyder Mark HowardSVP, CHIEF LEGAL OFFICER
|
Tax withholdingCommon Stock | 4,243 | $70.31 | $298,325.33 |
DisclosureSEC source: 0001159036-26-000005 · wk-form4_1767743723.xml · nonDerivative · entry 2 Snyder Mark Howard · CIK 0001902866 · SVP, CHIEF LEGAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,181 F1 · shares: The reported disposition of 4,243 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations. Read SEC document |
| January 03, 2026 Filed Jan 6, 2026 23:55 UTC |
Snyder Mark HowardSVP, CHIEF LEGAL OFFICER
|
Exercise / conversionCommon Stock | 7,611 | $0.00 | $0.00 |
DisclosureSEC source: 0001159036-26-000005 · wk-form4_1767743723.xml · nonDerivative · entry 1 Snyder Mark Howard · CIK 0001902866 · SVP, CHIEF LEGAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,424 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 23:56 UTC |
Lang James PaulDirector
|
GrantOption to Purchase Common Stock · Derivative | 1,342 | $0.00 Strike: $70.31 | $0.00 |
DisclosureSEC source: 0001159036-26-000007 · wk-form4_1767743799.xml · derivative · entry 2 Lang James Paul · CIK 0001703090 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,342 Underlying: Common Stock · 1,342 shares Expires 2036-01-02 F2 · derivative.exercise_date: Represents a stock options granted under the Issuer director compensation program. This grant will vest in full on the date of the Issuer 2026 annual meeting of stockholders. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 23:56 UTC |
Lang James PaulDirector
|
GrantRestricted Stock Units | 889 | $0.00 | $0.00 |
DisclosureSEC source: 0001159036-26-000007 · wk-form4_1767743799.xml · nonDerivative · entry 1 Lang James Paul · CIK 0001703090 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 889 F1 · shares: Represents restricted stock units granted under the Issuer's director compensation program. Each stock unit represents the right to receive one share of common stock and is scheduled to vest on the date of the Issuer's 2026 annual meeting of stockholders. These stock units are subject to a written deferral election under the Issuer's Directors Deferred Equity Compensation Plan pursuant to which shares of common stock are released to the reporting person upon completion of service as a director. Read SEC document |
| December 09, 2025 Filed Dec 11, 2025 23:16 UTC |
Torley HelenDirector · PRESIDENT AND CEO
|
GrantPerformance Stock Units · Derivative | 165,522 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001159036-25-000073 · wk-form4_1765494963.xml · derivative · entry 1 Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,522 Underlying: Common Stock · 165,522 shares Expires not disclosed F1 · shares: Represents the grant of performance-based vesting Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of HALO common stock. The target number of Restricted Stock Units subject to the award is indicated. Up to two hundred percent (200%) of the target Restricted Stock Units could vest if the average closing price of HALO common stock over a period of 20 consecutive trading days during a four-year performance period following the grant of the award equals or exceeds certain price levels specified in the award (with 50% of target number of units vesting at $115 and an additional 50% of the target number of units vesting at each of $130, $145 and $170) and, in each case, only if the Reporting Person remains employed with the Registrant through the end of the performance period (subject to certain exceptions provided in the applicable award agreement). F1 · derivative.exercise_date: Represents the grant of performance-based vesting Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of HALO common stock. The target number of Restricted Stock Units subject to the award is indicated. Up to two hundred percent (200%) of the target Restricted Stock Units could vest if the average closing price of HALO common stock over a period of 20 consecutive trading days during a four-year performance period following the grant of the award equals or exceeds certain price levels specified in the award (with 50% of target number of units vesting at $115 and an additional 50% of the target number of units vesting at each of $130, $145 and $170) and, in each case, only if the Reporting Person remains employed with the Registrant through the end of the performance period (subject to certain exceptions provided in the applicable award agreement). F1 · derivative.expiration_date: Represents the grant of performance-based vesting Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of HALO common stock. The target number of Restricted Stock Units subject to the award is indicated. Up to two hundred percent (200%) of the target Restricted Stock Units could vest if the average closing price of HALO common stock over a period of 20 consecutive trading days during a four-year performance period following the grant of the award equals or exceeds certain price levels specified in the award (with 50% of target number of units vesting at $115 and an additional 50% of the target number of units vesting at each of $130, $145 and $170) and, in each case, only if the Reporting Person remains employed with the Registrant through the end of the performance period (subject to certain exceptions provided in the applicable award agreement). Read SEC document |
| December 01, 2025 Filed Dec 2, 2025 00:50 UTC |
Connaughton BernadetteDirector
|
SaleCommon Stock | 829 | $71.60 | $59,356.40 |
DisclosureSEC source: 0001159036-25-000065 · wk-form4_1764636645.xml · nonDerivative · entry 1 Connaughton Bernadette · CIK 0001662521 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,123 F1 · kind: The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on May 29, 2025 in accordance with Rule 10b5-1. Read SEC document |
| December 01, 2025 Filed Dec 2, 2025 00:31 UTC |
Torley HelenDirector · PRESIDENT AND CEO
|
Exercise / conversionOption to Purchase Common Stock · Derivative | 16,569 | $8.11 Strike: $8.11 | $134,374.59 |
DisclosureSEC source: 0001159036-25-000063 · wk-form4_1764635501.xml · derivative · entry 7 Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,569 shares Expires 2026-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 21, 2025 in accordance with Rule 10b5-1. The sales of common shares reported on this Form 4 represent shares that were acquired following exercise of stock options with a ten-year term expiring in less than one year in February 2026. F6 · derivative.exercise_date: Grant to Reporting Person of options, exercisable over a 4-year period measured from the date of grant, 25% after 12 months, then 1/48th of the Option Shares per month thereafter. The date of grant was February 3, 2016. Read SEC document |
| December 01, 2025 Filed Dec 2, 2025 00:31 UTC |
Torley HelenDirector · PRESIDENT AND CEO
|
SaleCommon Stock | 261 | $71.60 | $18,687.60 |
DisclosureSEC source: 0001159036-25-000063 · wk-form4_1764635501.xml · nonDerivative · entry 6 Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 708,719 F2 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 21, 2025 in accordance with Rule 10b5-1. The sales of common shares reported on this Form 4 represent shares that were acquired following exercise of stock options with a ten-year term expiring in less than one year in February 2026. Read SEC document |
| December 01, 2025 Filed Dec 2, 2025 00:31 UTC |
Torley HelenDirector · PRESIDENT AND CEO
|
SaleCommon Stock | 500 | $70.36 | $35,181.00 |
DisclosureSEC source: 0001159036-25-000063 · wk-form4_1764635501.xml · nonDerivative · entry 5 Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 708,980 F2 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 21, 2025 in accordance with Rule 10b5-1. The sales of common shares reported on this Form 4 represent shares that were acquired following exercise of stock options with a ten-year term expiring in less than one year in February 2026. F5 · price: Represents a weighted average sales price per share. The shares were sold at prices ranging from $70.160 to $70.500. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| December 01, 2025 Filed Dec 2, 2025 00:31 UTC |
Torley HelenDirector · PRESIDENT AND CEO
|
SaleCommon Stock | 5,402 | $69.44 | $375,120.28 |
DisclosureSEC source: 0001159036-25-000063 · wk-form4_1764635501.xml · nonDerivative · entry 4 Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 709,480 F2 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 21, 2025 in accordance with Rule 10b5-1. The sales of common shares reported on this Form 4 represent shares that were acquired following exercise of stock options with a ten-year term expiring in less than one year in February 2026. F4 · price: Represents a weighted average sales price per share. The shares were sold at prices ranging from $69.160 to $70.100. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| December 01, 2025 Filed Dec 2, 2025 00:31 UTC |
Torley HelenDirector · PRESIDENT AND CEO
|
SaleCommon Stock | 10,406 | $68.51 | $712,935.87 |
DisclosureSEC source: 0001159036-25-000063 · wk-form4_1764635501.xml · nonDerivative · entry 3 Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 714,882 F2 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 21, 2025 in accordance with Rule 10b5-1. The sales of common shares reported on this Form 4 represent shares that were acquired following exercise of stock options with a ten-year term expiring in less than one year in February 2026. F3 · price: Represents a weighted average sales price per share. The shares were sold at prices ranging from $68.100 to $69.080. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| December 01, 2025 Filed Dec 2, 2025 00:31 UTC |
Torley HelenDirector · PRESIDENT AND CEO
|
Exercise / conversionCommon Stock | 16,569 | $8.11 | $134,374.59 |
DisclosureSEC source: 0001159036-25-000063 · wk-form4_1764635501.xml · nonDerivative · entry 2 Torley Helen · CIK 0001528185 · Director · PRESIDENT AND CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 725,288 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on March 21, 2025 in accordance with Rule 10b5-1. The sales of common shares reported on this Form 4 represent shares that were acquired following exercise of stock options with a ten-year term expiring in less than one year in February 2026. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.